| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |